Nanite Bio is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER ™ combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles for cargo.
The company has raised a total of $8.0M in total equity funding and is backed by Cystic Fibrosis Foundation.
You can learn more about their platform at https://www.nanitebio.com/platform.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $8M
Founded date: 2020
Funding Rounds 2
Date | Series | Amount | Investors |
15.03.2023 | - | $2M | - |
15.02.2023 | Seed | $6M | Zetta Vent... |
Mentions in press and media 6
Date | Title | Description | Source |
15.03.2023 | Nanite Receives Up to $2M Investment | BOSTON, MA, Nanite Inc. announced an investment from the Cystic Fibrosis Foundation of up to $2 mi... | vcnewsdail... |
15.03.2023 | Nanite Receives Up To $2M Investment from Cystic Fibrosis Fo... | Nanite, a Boston, MA-based non-viral gene delivery company, received up to $2M in funding. The roun... | finsmes.co... |
15.02.2023 | Nanite Closes $6M in Seed Funding | Nanite, a Boston, MA-based provider of an AI-driven polymer design platform, raised $6M in Seed fund... | finsmes.co... |
15.02.2023 | Nanite Debuts AI-Driven Polymer Design Platform for Gene Del... | Nanite announced the closing of a $6M seed investment round to advance their AI-driven polymer desig... | aithority.... |
15.02.2023 | Nanite Announces $6M Seed Investment Round | BOSTON, MA, Nanite Inc. announced the closing of a $6M seed investment round led by Zetta Venture ... | vcnewsdail... |
- | Nanite | “Nanite Bio” | fastfounde... |